Sara Bonstein is Chief Financial Officer of INSMED Inc. Currently has a direct ownership of 118,863 shares of INSM, which is worth approximately $9.69 Million. The most recent transaction as insider was on Jan 11, 2022, when has been sold 1,154 shares (Common Stock) at a price of $25.11 per share, resulting in proceeds of $28,977. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 119K
1.18% 3M change
4.22% 12M change
Total Value Held $9.69 Million

Sara Bonstein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 11 2022
SELL
Open market or private sale
$28,977 $25.11 p/Share
1,154 Reduced 3.11%
35,979 Common Stock
Jan 06 2022
BUY
Grant, award, or other acquisition
-
13,006 Added 25.94%
37,133 Common Stock
May 12 2021
BUY
Grant, award, or other acquisition
-
14,172 Added 37.76%
23,355 Common Stock
Jan 07 2021
BUY
Grant, award, or other acquisition
-
9,183 Added 50.0%
9,183 Common Stock

Also insider at

SCPH
scPharmaceuticals Inc. Healthcare
XLO
Xilio Therapeutics, Inc. Healthcare
SB

Sara Bonstein

Chief Financial Officer
Bridgewater, NJ

Track Institutional and Insider Activities on INSM

Follow INSMED Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INSM shares.

Notify only if

Insider Trading

Get notified when an Insmed Inc insider buys or sells INSM shares.

Notify only if

News

Receive news related to INSMED Inc

Track Activities on INSM